We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Parker Laboratories

Manufactures medical ultrasound and electromedical contact media, including gels, solid gels, lotions and pads read more Featured Products: More products

Download Mobile App

Parker Laboratories Introduces Groundbreaking Ultrasound Innovations

By HospiMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Tristel ULT is a high-level disinfectant foam to disinfect cleaned, reusable, non-lumened ultrasound probes (Photo courtesy of Parker Labs)
Image: Tristel ULT is a high-level disinfectant foam to disinfect cleaned, reusable, non-lumened ultrasound probes (Photo courtesy of Parker Labs)

Parker Laboratories Inc. (Fairfield, NJ, USA) is introducing innovative ultrasound products at MEDICA 2023 that are designed to increase patient safety, lower costs, and improve workflow in busy healthcare settings that rely on point-of-care ultrasound. The company is introducing the UltraDrape II UGPIV Barrier and Securement Dressing and Tristel ULT high-level disinfectant foam that promotes patient safety while reducing costs and increasing efficiency for ultrasound-guided percutaneous procedures.

Ultrasound technologies offer important advantages for vascular access procedures such as inserting central lines and peripheral catheters, improving outcomes while also reducing risks and healthcare costs. Hospitals are seeing an increase in the number of patients with difficult vascular access (DiVA) who require ultrasound guidance to achieve peripheral vascular access. UltraDrape II is the next generation of Parker’s groundbreaking UltraDrape, the only dressing designed specifically for use during UGPIV procedures. Like the original, UltraDrape II is a sterile, dual-action barrier and securement dressing that provides a “gel-free” insertion site to decrease the risk of contamination and securement failure both during and after UGPIV procedures.

Tristel ULT is a high-level disinfectant that uses unique, proprietary foam containing chlorine dioxide for reprocessing ultrasound probes. It was recently granted FDA clearance for use as a high-level disinfectant for ultrasound probes used within body cavities and for skin-surface transducers, making it the first product of its kind to be available in the United States. Tristel ULT is the only high-level disinfectant foam that can be safely used on ultrasound probes, and it has been shown to be effective against pathogens ranging from SARS-CoV-2 to Mycobacterium tuberculosis. As a rapid and inexpensive high-level disinfectant, Tristel ULT represents an important advance offering several advantages over other methods of high-level disinfection currently on the market.

“As the use of ultrasound guidance for vascular access procedures increases, so does the need for supplies that make these procedures safer and more efficient, without increasing costs,” said Neal Buchalter, president of Parker Laboratories. “These new products are just a few of the innovative and cost-effective solutions we are committed to bring to market to increase patient safety and improve workflow for busy vascular access clinicians.”

Related Links:
Parker Laboratories Inc.

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Specimen Collection & Transport
Ferromagnetic Hand-Held Detector
FerrAlert Target Scanner
Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit

Print article


Critical Care

view channel
Image: Investigators are developing synthetic programmable bacteria to help kill cancerous tissue (Photo courtesy of Texas A&M University)

Programmable Bacteria Could Cure Cancer with Single $1 Dose

Cancer treatments have traditionally faced challenges such as harmful side effects, limited patient responsiveness, and high costs. A significant percentage of cancer survivors and patients are burdened... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The patented 3TR technology delivers proven PCR-level sensitivity and specificity (Photo courtesy of 3EO Health)

High-Performing Low-Cost Diagnostic Platform Provides Molecular Results At Near Antigen Pricing

When it comes to point-of-care respiratory diagnostic products, there's often a trade-off between performance and affordability. Current molecular diagnostic solutions are high-performing but expensive... Read more
Medica 2023
Copyright © 2000-2023 Globetech Media. All rights reserved.